Development of experimental models by genetic manipulation in mice has proven to be very useful in determining the significance of particular genes in the development of or susceptibility to hypertension. Advances in molecular genetics, transgenic mouse technology, and physiological measurements in mice provided an opportunity to go a step further and develop models to analyze the physiological significance of specific gene variants potentially causing hypertension. In this report, we describe the development of a human angiotensinogen transgenic mouse model generated by targeting the human angiotensinogen gene upstream of the mouse HPRT locus by homologous recombination. The main benefit of this transgenic mouse model is that the human angiotensinogen gene is inserted into the mouse genome as a single copy at a predefined locus and in a specific orientation-a process that can be repeated utilizing other variants of this gene. We establish the validity of this approach by showing that the hAGT hprt mice have normal tissue-and cell-specific expression of the human angiotensinogen gene and normally produce and process the hAGT protein at physiological levels.
Development of experimental models by genetic manipulation in mice has proven to be very useful in determining the significance of particular genes in the development of or susceptibility to hypertension. Advances in molecular genetics, transgenic mouse technology, and physiological measurements in mice provided an opportunity to go a step further and develop models to analyze the physiological significance of specific gene variants potentially causing hypertension. In this report, we describe the development of a human angiotensinogen transgenic mouse model generated by targeting the human angiotensinogen gene upstream of the mouse HPRT locus by homologous recombination. The main benefit of this transgenic mouse model is that the human angiotensinogen gene is inserted into the mouse genome as a single copy at a predefined locus and in a specific orientation-a process that can be repeated utilizing other variants of this gene. We establish the validity of this approach by showing that the hAGT hprt mice have normal tissue-and cell-specific expression of the human angiotensinogen gene and normally produce and process the hAGT protein at physiological levels.
Hypertension is a multifactorial disorder exhibiting polygenic inheritance. Since the angiotensinogen (AGT) 1 gene was shown to be genetically linked to hypertension, there has been a search for specific mutations in the human AGT sequence that could be causative of the disorder (1) . Whereas a number of single nucleotide polymorphisms have been identified in the coding region, in introns, and within the promoter region of the gene, only one haplotype has been reported by independent research teams to associate with the hypertensive phenotype. This haplotype consists of two single base change alleles which exist in strong linkage disequilibrium, a G 3 A substitution at position Ϫ6 of the promoter and a T 3 C substitution in codon 235 changing it from methionine to threonine (2) . The associations were derived from studies in which the frequency of the Ϫ6A/235Thr allele was analyzed with respect to blood pressure and other cardiovascular disorders like plasma angiotensinogen levels, coronary atherosclerosis, or coronary heart disease (1) (2) (3) (4) (5) (6) (7) (8) . However, among dozens of linkage, association, and case-control studies on this subject, substantial controversy remains regarding the significance of this genetic alteration in hypertension (Ref. 9 -13 ; and reviewed in Ref. 14) .
The number of reports and their conflicting conclusions illustrate the difficulties encountered in addressing and understanding the genetics of polygenic diseases. Corvol et al. (15) recently described that it is very difficult to rigorously prove the significance of a genetic polymorphism utilizing only linkage analysis when the phenotype is polygenic and multifactorial in nature and when the populations are ethnically diverse. For example, the frequency of the Ϫ6A/235Thr allele is disproportionate among different ethnic groups, being prominent in African and Japanese populations whereas the Ϫ6G/235Met haplotype is predominant in people of European descent (2, 11, 16, 17) . Because of these issues, studies must be performed in large populations to ensure adequate statistical power. Evidence of linkage is generally a statistical one governed by the modest excess of one allele in hypertensive over normotensive subjects. Thus, these studies can only establish an association between a phenotype and a gene but not prove causality. It is therefore essential to establish the significance of a genetic mutation experimentally by performing biochemical and functional studies.
Understanding these limitations, we developed an experimental system using gene targeting to accurately assess the physiological significance of gene variation in the human AGT gene. The system is based on studies by us and others which established that: 1) the human renin and human AGT genes can functionally complement abnormalities in the mouse AGT gene induced by gene targeting (18) and 2) that gene targeting can effectively deliver a transgene in a single copy to a selected locus in the genome (Ref. 19; and reviewed in Ref. 20) . Here we report the development and characterization of a transgenic mouse model in which gene targeting at the HPRT locus was used to selectively target a single copy of the human AGT gene to a known site in the genome. We demonstrate that insertion of the single copy transgene upstream of HPRT does not affect the overall tissue-and cell-specific expression or hormonal regulation of human AGT. This study provides an important proof-of-principal that the functional significance of allelic variation in human AGT can be assessed by examining mice carrying transgenes targeted in a single copy to an identical insertion site.
MATERIALS AND METHODS
Generation of the Model-Genomic human AGT construct spanning all five exons and accompanying introns as well as 1.5 kb of 5Ј and 0.3 kb of 3Ј region was subcloned as a NotI fragment into a pMP8SKB HPRT vector (19) , resulting in a 27-kb pMPGLM targeting vector. 10 7 BK4 ES cells were electroporated in ES cell medium (Dulbecco's modified Eagle's-Ham's medium with L-glutamine and glucose (4500 mg/l)) with 10 g of PvuI linearized pMPGLM plasmid using voltage and capacitance settings of 250V and 500 microfarads, respectively. ES cells were plated 1:4 on plates containing a layer of fibroblast feeder cells and were grown in ES cell culture media containing LIF (1000 u/ml) and 20% fetal calf serum. After 24 h, the media was substituted with selective HAT media (ES cell media containing LIF, fetal calf serum, hypoxanthine (0.016 mg/ml), aminopterin (0.175 g/ml), and thymidine (0.0048 mg/ml)), and the cells were grown for one week. HAT-resistant colonies were isolated, expanded, and a portion used for DNA analysis. Chimeric mice were generated using routine procedures.
Genomic DNA preparations from ES cells or mouse tails were used in a PCR reaction with oligonucleotides that specifically amplify 550 bp of human angiotensinogen sequence (5Ј-TGGTGCTAGTCGCTGCAAAAC-TTGACACCG-3Ј and 5Ј-CAGGGAGCAGCCAGTCTTCCATCCTGTCA-C-3Ј) as described previously (21) . Approximately 10 g of genomic DNA from individual targeted ES cell clones, and/or control BK4 and R1 ES cells, was digested with BamHI enzyme overnight and resolved on a 0.8% agarose gel. Membranes were probed overnight with a radioactively labeled DNA probe which hybridizes to a 250-bp sequence located in the third intron of the endogenous HPRT gene. After washing, the membranes were analyzed using a Storm 820 PhosphorImager TM system (Molecular Dynamics).
Analysis of Expression-Tissues were harvested following CO 2 asphyxiation and snap-frozen in liquid N 2 , and RNA was prepared using TRI-Reagent (Molecular Research Corp.) as suggested by the manufacturer. For tissue-specific expression, 25 or 30 g of individual RNA preparation (or the whole RNA preparation in case of tissues such as aorta and adrenal gland) was used per assay, and samples were resolved on a 0.5% agarose gel. Membranes were probed overnight with radioactively labeled RNA probe spanning nucleotides 302-931 of the human AGT cDNA sequence. After washing, the signals were detected using x-ray film (Kodak) or Storm 820 phosphorimager system (Molecular Dynamics).
RPA was performed using HybSpeed RPA kit (Ambion) according to manufacturer's specifications. Each RNA sample was incubated with the human AGT and mouse actin probes (specific activity Ϸ20,000 cpm) which resulted in protected fragments of 518 and 250 bp, respectively. All samples were run on the same gel and bands quantified using Storm 820 PhosphorImager TM system and ImageQuant Version 4.0 software (Molecular Dynamics). Data was normalized using mouse actin and analyzed using SigmaStat graphing program.
For immunocytochemical analysis, kidney and liver segments were isolated from either transgenic mice or nontransgenic littermates and fixed in 4% paraformaldehyde for 2 h, transferred to 30% sucrose solution, and kept at 4°C overnight. Next day, tissues were frozen in OCT and sectioned at 8 -10 m. Slides were rinsed with Superblock (Pierce) for 5 min followed by a 10-min incubation with 0.1% Triton X-100 in Superblock at room temperature. Permeabilized sections were then incubated with rabbit anti-human AGT primary antibody overnight at 4°C. The slides were washed with phosphate-buffered saline (3ϫ for 10 min), incubated with secondary Cy3-labeled donkey antirabbit antibody at 37°C for 2 h, and washed again 3ϫ for 10 min in phosphate-buffered saline. Confocal microscopy was performed using a Bio-Rad MRC-1024 Hercules Laser Scanning Confocal Microscope equipped with a Kr/Ar laser.
Equal volume whole plasma samples (5 l) were loaded onto 10% polyacrylamide gels and electrophoretically transferred onto nylon membranes. The membranes were either stained with Coomassie Blue to visualize total protein or used to detect human AGT protein. For human AGT protein detection, the membrane was probed with 1:1000 dilution of primary rabbit anti-human AGT and detected with colorimetric assay utilizing horseradish peroxidase-conjugated secondary goat anti-rabbit antibody (ECL Western blotting analysis system, Amersham Pharmacia Biotech).
Endocrinology-Mouse and human AGT can be differentiated in the plasma on the basis of the strict species-specificity of the biochemical reaction between renin and AGT (22) . Plasma samples were collected from mice immediately following CO 2 asphyxiation. Approximately 500 l of whole blood was collected at each bleed and placed in chilled tubes containing 2.5 l of 0.5 mol/l EDTA. The specimens were then immediately centrifuged at 12,000 rpm for 10 min at 4°C, and two 250-l plasma samples were obtained and immediately frozen at Ϫ80°C. Generation of Ang-I and radioimmunoassay was performed as described previously (21) . Radioimmunoassays were performed using the RIANEN Angiotensin I 125 I-labeled RIA kit (DuPont Co., Billerica, MA) using the directions and reagents supplied by the manufacturer. Samples were appropriately diluted with reagent blank so that the radioimmunoassay results were on the linear portion of the standard curve. Plasma levels of AGT were then extrapolated using the 1:1 molar relationship between Ang-I and its precursor, AGT, using the formula: ng Ang-I/ml ϫ 0.77 pmol/ng Ang-I ϫ 0.05 g hAGT/pmol.
Physiology-Blood pressure was measured in conscious, freely moving mice surgically instrumented with a left common carotid artery catheter (0.04 in outer diameter ϫ 0.025 in inner diameter, Microrenathane; Braintree Science Inc., Braintree, MA) as described (23) . The blood pressure response to infusions of purified recombinant human renin were made via a catheter implanted into the right jugular vein as described (24) . Recombinant human renin was the kind gift of Drs. Walter Fischli and Klaus Lindpaintner at F. Hoffman-LaRoche, Basel Switzerland. To assess specificity of the response, mice were given captopril (20 mg/kg, intravenously) or a known pressor response dose of Ang-II (10 mg/kg) (25). 
FIG. 2. ES cell targeting and development of transgenic mice.
HAT-resistant ES cell clones were analyzed for the presence of the hAGT gene by PCR using hAGT-specific primer set (A) and by Southern blot using rsa probe (B). Note that clone 7 contains two insertions, one upstream of HPRT, and one at another undefined location in the genome. A cross between a male chimeric mouse with a high degree of chimerism, derived from clone 1, and three C57BL/6J females resulted in 15 offspring that were analyzed for the presence of the hAGT transgene by PCR (C) and for single copy integration at the HPRT locus by Southern blot (D). M, 100-bp ladder; Ϫ, water negative control; ϩ, plasmid carrying human AGT gene positive control; B or BK4, BK4 cell DNA; ES, DNA from clone 3; R1, R1 cell DNA with wild-type HPRT locus.
RESULTS
To target the human AGT in a single copy upstream of the HPRT locus, we generated a targeting vector consisting of a segment of genomic DNA containing the complete human AGT coding sequence into the pMP8SKB vector (19) . The targeting vector was transfected into BK4 cells, an HPRT-deficient E14Tg2a ES cell line. This cell line lacks the promoter and first two exons of HPRT, rendering it sensitive in HAT media. The targeting vector contains two regions of homology upstream and downstream of HPRT to facilitate recombination, the promoter and first two exons of HPRT missing in BK4 cells, and the human AGT gene (Fig. 1A) . Successful homologous recombination corrects HPRT deficiency, restoring the ability of BK4 cells to grow in HAT medium, and simultaneously inserts the human AGT gene upstream of the locus (Fig. 1, B and C) . HAT-resistant colonies were first screened for the presence of the human AGT transgene using specific PCR primers ( Fig. 2A) and second by Southern blot for the presence of a single integration event at the HPRT locus (Fig. 2B) . This approach was highly efficient in creating independently targeted ES clones (summarized in Table I ).
Three targeted BK4 clones were expanded and used to create chimeric mice by blastocyst injection. The resulting chimeric male mice had varying degrees of BK4 cell contribution based on an assessment of coat color (approximately 5, 10, and Ͼ95%). The chimera with the highest degree of BK4 cell contribution was 100% efficient in transmitting the BK4 genome when mated with C57BL/6J mice, as judged by the agouti coat color of the offspring, whereas the other two failed to transmit the ES cell genome. Because BK4 ES cells are male cells and HPRT locus is located on the X chromosome, only female offspring from the initial cross could receive the human AGT transgene. Indeed, subsequent analysis of DNA from offspring by PCR (Fig. 2C ) and Southern blot (Fig. 2D) confirmed the generation of only female transgenic mice.
Upon establishing the hAGT hprt transgenic line, we analyzed the tissue-specific expression of the transgene and compared it with a previously established multicopy human AGT transgenic mouse line generated by standard pronuclear injection (Fig. 3) (21, 26) . Abundant human AGT mRNA was detected in liver and kidney of both the multicopy and hAGT hprt transgenes, with lower levels detected in tissues such as heart, brain, white and brown adipose tissue, diaphragm, and aorta. Only minor anomalies were observed, including diminished expression in adrenal gland of both male and female hAGT hprt mice and increased expression in kidney of male hAGT hprt mice. These results strongly suggest that integration of the human AGT transgene upstream of the HPRT locus does not have a significant effect on its expression.
Cell-specific expression of the human AGT protein was tested by immunohistochemistry in two of the most abundantly expressing tissues-liver and kidney. Fluorescent signals specific to human AGT protein expression were restricted to proximal tubule cells of the renal cortex (Fig. 4) and hepatocytes of the liver (Fig. 5) . These are both well established sites of AGT expression indicating correct cell-specific expression of the transgene. It is interesting to note that, whereas male and homozygous female transgenic mice had uniformly high expression of human AGT throughout the liver, the expression pattern in heterozygous female transgenic mice was variegated. This likely reflects the functional random inactivation of genes located on the X-chromosome of female mice. A similarly variegated pattern was observed in the kidney. Our quantification of the level of hAGT hprt mRNA in liver and kidney is also consistent with a pattern of random X-chromosome inactivation. The level of hepatic (Fig. 6A) and renal (Fig. 6B) hAGT hprt mRNA in homozygous female transgenic mice was twice that of heterozygous female mice.
Angiotensinogen expression is known to be regulated by androgens in kidney (27) , and the level of human AGT mRNA in kidneys of male hAGT hprt mice was higher than that of female mice (Fig. 3) . This was examined in more detail in hAGT hprt mice by measuring human AGT expression in kidney and liver following castration and subsequent administration of a subcutaneous pellet containing testosterone. Human AGT mRNA in kidney was reduced following castration, when compared with sham-operated control, and was restored to baseline levels by testosterone (Fig. 7) . As expected, expression of the transgene in liver was unaffected by the same protocol.
We 
Expression of Single Copy Transgene at the HPRT Locus
mice is correctly processed in the liver and secreted into plasma. Similar to hepatic hAGT hprt mRNA, the levels of circulating human AGT, as detected by its conversion to Ang-I in the presence of exogenous human renin, was equivalent in hemizygous male and homozygous female transgenic mice and about twice that of heterozygous female mice (Fig. 6C) . Western blot analysis indicated the characteristic banding pattern of human AGT protein with an approximate size of 50 kDa (Fig.  8) , suggesting the protein was appropriately processed and released into the systemic circulation. We previously demonstrated that unlike most transgenes, expression of the human AGT gene in transgenic mice was proportional to copy number (26) . Indeed, the level of circulating human AGT in the hAGT hprt mice was substantially lower than that observed in a standard multicopy transgenic mouse (Fig. 8B ). This is particularly important as our ability to make direct comparison among allelic constructs using this method will require near physiologic levels of the transgene products. Because of species-specificity in renin-angiotensinogen enzymatic reaction, human AGT protein is essentially inert in the plasma of a mouse. Therefore, to formally prove the physiologic activity of human AGT present in the circulation, we measured blood pressure responses to acute intravenous infusion of purified recombinant human renin. Administration of 500 ng of human renin induced an acute increase in blood pressure (⌬BP ϭ 25.6 Ϯ 2.0 mmHg, n ϭ 6) in hAGT hprt mice (Fig. 9A ). This pressor response could be repeatedly observed by additional infusion cycles (data not shown). That this was mediated by the cleavage of human AGT by human renin was proven by the abrogation of the pressor response after administration of captopril, an inhibitor of angiotensin-converting enzyme (Fig.  9B) . Even after captopril treatment, these mice responded with a pressor response to direct infusion of purified Ang-II (⌬BP ϭ 38.6 Ϯ 4.4 mmHg, n ϭ 7, Fig. 9C ). It is important to note that the pressor response in the hAGT hprt mice to human renin was significantly less than that caused by Ang-II infusion, again suggesting that the levels of human AGT in the circulation were in the physiologic range. Relative expression of human AGT mRNA was analyzed by RNase protection assay using mouse actin as an internal control and quantified as described under "Material and Methods." Homozygous (ϩ/ϩ) female mice had about 2-fold higher expression in both liver (panel A, *, p ϭ 0.011; n ϭ 5) and kidney (panel B, *, p ϭ 0.022; n ϭ 5) as compared with heterozygous (ϩ/Ϫ) transgenic female mice. C, analysis of plasma hAGT levels by measuring Ang-I (AI) conversion using radioimmunoassay similarly showed significantly decreased levels of hAGT protein in heterozygous transgenic female hAGT hprt mice (n ϭ 6) as compared with both transgenic male (*, p ϭ 0.021; n ϭ 6) and homozygous female mice (*, p ϭ 0.021; n ϭ 6).
FIG. 7. Androgen responsiveness of human AGT expression.
Androgen responsiveness of hAGT was analyzed in male transgenic hAGT hprt mice. Six mice were separated into two groups. Two mice were sham-operated (S) and used as a control and four mice were castrated. After 4 days, the sham-operated mice and two of the castrated mice (C) were sacrificed, and liver and kidney tissues were isolated and frozen. The other two castrated mice received subcutaneous testosterone pellets (CT) and were sacrificed 3 days following implantation, at which point liver and kidney tissues were isolated and frozen. RNA from all tissues were prepared at the same time, and levels of hAGT message were analyzed by Northern blot. Amounts of RNA used in the blot are represented at the bottom of the figure by a segment of a methylene blue-stained filter indicating 28 S rRNA.
DISCUSSION
We selectively targeted the human AGT gene to the mouse HPRT locus by employing ES cells harboring a deletion in the endogenous HPRT gene and a special targeting vector capable of restoring its full functionality upon homologous recombination (19, 28) . The use of gene targeting is essential in developing a model for studying effects of allelic gene variants in vivo because it nullifies the copy number and positional effects associated with transgene expression in transgenic mouse models generated by pronuclear injection. It allows reproducible insertion of the single copy of a transgene in a predetermined locus, permitting direct comparison between individually generated transgenic lines. Furthermore, independently derived transgenic mice generated by gene targeting are genetically identical, abolishing the need for multiple transgenic mouse lines harboring the same construct. The largest benefit of our strategy is the highly reproducible efficiency in selecting single homologous recombination events. This should allow for relatively easy development of a number of transgenic ES cell clones that harbor specific variants of a gene of interest, and a subsequent generation of transgenic mice.
Of course, we must recognize certain drawbacks of using a nonnative locus, such as HPRT, for gene targeting. Exogenous genes may not harbor all of the sequences necessary and sufficient for proper regulation of expression and may therefore be influenced by cis-acting regulatory elements in the vicinity of the HPRT gene. Although the HPRT gene is essentially ubiquitously expressed, three studies reported preferential expression of certain transgenes in some but not other tissues (19, 29, 30) . However, two of those studies used a different methodology in their targeting by employing the neomycin resistance gene and G418 selection. Moreover, while transgene expression in the animals was studied in two reports, the third utilized teratocarcinoma cells derived from targeted ES cells. In addition, it is possible that the transgenes in those studies lacked all of the elements required for their normal expression. Our previous studies indicate that the 13.8-kb genomic human AGT transgene, identical to the one used in this study, is expressed in a tissue-and cell-specific and copy-number proportional fashion in transgenic mice, suggesting that all essential regulatory elements are present in the transgene (26) . Another difference is that the transgene in our model is transcribed in the reverse orientation relative to the endogenous HPRT locus, which has been shown to have a beneficial effect on the expression of a transgene (30) .
Another potential drawback of targeting the HPRT locus is that it is located on the X chromosome and the transgene expression is affected by random X inactivation, as we have demonstrated in our mice. This means that one can effectively achieve an equivalent of 1 copy (in the case of male and homozygous transgenic female mice) or 0.5 copy (in the case of heterozygous transgenic female mice) transgene expression. This should not be of a great concern in employing such mice in the analysis of transgene variants as long as it is considered in the final data analysis. For example, one could compare two or more lines of mice transgenic for different gene variants and could stratify the data according to mouse gender and/or zygosity. In fact, it is conceivable that lower levels of transgene expression might be beneficial in identifying modest molecular and physiologic changes between specific allelic variants.
Our data indicate that the human AGT gene was apparently unaffected by the HPRT locus. It exhibited correct tissue and cell specificity and was properly regulated by the changes in testosterone levels. Furthermore, the human AGT protein was normally processed, and its plasma concentration was proportional to the level of human AGT mRNA indicating proper regulation. The protein in plasma is readily cleaved by human renin, resulting in the acute pressor response which could be easily detected by changes in blood pressure. We also showed that we are capable of detecting relatively small differences in expression levels of both RNA and protein, comparable with the proposed differences among Ϫ6G/235Met and Ϫ6A/235Thr alleles (31) . This model should, therefore, be suitable in the analysis of the most significant human AGT variants described to date.
